Already Registered? Log In Now
Not Registered?
Business Email:
Complete this form to enter the webcast.
Already Registered?
(* indicates required field)
Complete this form to enter the webcast.
(* indicates required field)
Business Email*:
First Name*:
Last Name*:
Title*:
Company Name*:
Country*:
--
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Which best describes your job function?:
--
Clinical Research
Commercial Operations
Commercialization
Compliance
Consultant
Contract Services
Corporate Management
Drug Safety
Engineering
Environmental
Finance
HR
IT
Lab Management
Legal
Managed Care
Manufacturing/Processing
Market Research
Marketing
Media Planning
Medical Affairs
Medicare/Medicaid
Meeting Planner
Other
Packaging
Patient Programs/Services
Pharmacy
Procurement
Project Management
QA/QC
R&D
Regulatory Affairs
Reimbursement
Sales Management
Scientific
Supply Chain
Technology Transfer
Trade/Sales
Validation
X-Outcomes
Which best describes your business/industry?:
--
Academic
Audit & Financial Advisory
Biopharma
Bio Pharmaceutical
Biotech
Consultant
Contract Manufacturing Organization (CMO)
Contract Research Organization (CRO)
Convention/Visitors Bureau
Data Management/Technology Provider
Diagnostics
DMC (Destination Management Company)
Food
Government
Health Plan/Payer
Hospital/Medical Centers
Hotel
Laboratory
Legal/Law Firm
Marketing/Creative Agency
Medical Device
Non Profit
PBM (Pharmacy Benefit Management)
Pharmaceutical
Retail Pharmacy
Solutions Provider
Third Party Meeting Manager
Wholesaler/Distributer
checked
Yes, please subscribe me to BioPharm International's free e-newsletters.
By registering for this event, you agree to MJH Life Sciences ®
Terms and Conditions
,
Privacy Policy
, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact
info@mjhassoc.com
.
Discover Polyplus Solutions:
Click Here
*Denotes required.
Next Generation of Genetic Engineered AAV Helper Plasmids
This event is now available On-Demand.
Event Overview:
Harnessing rAAVs as viral vectors for therapeutic transgene delivery still requires improvements in yields and specificity to lower vector doses, and therefore manufacturing cost, as well as to improve patient safety. To this end, research is focused on developing novel technologies to ensure manufacturing of high yielding rAAV particles using transient transfection.
Join this webinar to hear from Eric Mauro, plasmid engineering scientist, Polyplus, and Goutham Kumar Ganjam, head of manufacturing, DiNAMIQS, as they discuss Polyplus’ state-of-the art approach to design new helper plasmids (phelpers) with the aim of improving both the infectiosity (TU/mL) and the quality (full/empty ratio) of the viral particle in suspension systems. Eric and Goutham will also highlight how DiNAMIQS evaluated these novel helper plasmids in their manufacturing platform and what was learned about the potential to improve both productivity and quality of rAAV produced.
Key Learning Objectives:
Strategies to improve AAV helper plasmid engineering.
Role of engineering of helper plasmid to improve AAV yield and quality.
Who Should Attend:
Big Pharma Companies (Pfizer, Sanofi, GSK, etc.)
C&G Biotech Companies working on cell therapies, viral vectors and pDNA.
Small Biotech Companies dealing with gene editing (not only viral vector) and engineered cells.
Life Science and Biopharmaceutical Industry Consultants.
Featured Speakers
Eric Mauro
Plasmid Engineering Scientist
Polyplus
Eric Mauro
received his PhD in virology, working on retroviruses in Bordeaux (France) in 2018. Eric moved on to carry out postdoctoral training and worked on the development of therapeutic drugs against retroviruses. He then joined the plasmid engineering site of Polyplus, a Sartorius Company, as a plasmid engineering scientist in 2020. In his current role, Eric develops strategies to improve rAAV production for gene therapy.
Speaker's Email:
emauro@polyplus-transfection.com
Speaker's LinkedIn:
Eric Mauro
Goutham Kumar Ganjam
Head of Manufacturing
DiNAMIQS
Goutham Kumar Ganjam
is head of AAV manufacturing at DiNAMIQs, a Siegfreid company, based in Zurich Switzerland, and is responsible for delivering R&D grade AAV to accelerate AAV-based gene therapies from proof-of-concept studies to TOX studies. He is involved in early process development, from gene cassette optimization, to suspension-based AAV manufacturing up to 50L scale. Goutham earned his PhD in Biochemistry from Georg-August University of Göttingen. The author of more than 20 scientific publications, Goutham developed AAV-based neurodegenerative and metabolic disease models supported by Roche, ParkinsonFonds, Rönten-Behring and Deutcsche Forschungsgemeinshaft.
Speaker’s Email:
goutham@dinaqor.com
Speaker's LinkedIn:
Goutham Kumar Ganjam
For any technical questions please contact Morgan Marant:
mmarant@mjhevents.com
FAQs and System Test
Outlook ❯
Google ❯